The global healthcare visual inspection services market size is expected to reach USD 7.08 billion by 2030, registering a CAGR of 9.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growth in the market can be attributed to benefits offered by healthcare visual inspection, such as cost savings, increased quality assurance, revolutionizing quality control processes, and enhanced operational efficiency. Besides, in pharmaceutical and medical devices, the inspection process improves the quality, further saving costs for manufacturers.
In addition, visual inspection systems support healthcare companies in harnessing their capabilities, further elevating their quality control standards, driving cost efficiencies, and optimizing production processes to stay competitive in the dynamic industrial landscape. It further supports delivering superior products consistently, reducing waste, and efficiently operating, ultimately fueling growth and success.
Moreover, automation, artificial intelligence (AI), and machine learning are some of the key factors fueling the market. Manufacturers are increasingly opting for healthcare visual inspection to enhance efficiency, reduce human error, and improve defect detection. Besides, rising investments in biopharmaceutical research and development (R&D) and growing presence of established contract development and manufacturing organizations (CDMOs), contract manufacturing organizations (CMOs), and contract research organizations (CROs) contribute to market growth.
Moreover, stringent regulatory requirements from the FDA, EMA, and MHRA have made healthcare visual inspection services essential for ensuring the safety, efficacy, and compliance of pharmaceutical and medical device products. Besides, standards like USP <790>, USP <1790>, and EU GMP Annex 1 are necessary for particulate matter detection and improved inspection systems. Hence, to comply, most manufacturers are integrating real-time data analytics, predictive maintenance, and AI-driven defect classification to ensure regulatory adherence and minimize recalls.
Hence, healthcare companies are shifting towards visual inspection services for automation, real-time compliance monitoring, and AI-assisted decision-making. These advancements enhance precision, efficiency, and product safety, reinforcing the importance of innovation in ensuring high-quality healthcare manufacturing. Therefore, this has led to an increasing need for these services, leading to increasing outsourcing of visual inspections and seeking cost-effective and specialized expertise with their emerging pipelines. Such factors are expected to drive the market over the estimated period.
Request a free sample copy or view report summary: Healthcare Visual Inspection Services Market Report
The pharmaceutical segment dominated the market, with a share of 65.15% in 2024. Growth in the segment can be attributed to the increasing focus on quality assurance of pharmaceutical products & medical devices. In addition, cost efficiency, product compliance, and a growing focus on product safety are expected to drive the segment growth.
Based on technology, the semi-automated visual inspection (SAVI) segment held the largest market share in 2024, attributed to the stringent regulatory requirements, growing demand for medical devices & pharmaceutical drugs, and rapid adoption of automation. Besides, semi-automation offers an easy and practical examination of ampoules, vials, cartridges, and syringes carrying injectable liquids, powders, or freeze-dried products.
Based on the end use, the pharmaceutical and biopharmaceutical companies segment dominated the market, accounting for 49.82% in 2024. This is attributable to increasing pharmaceutical drug demand, the growing burden of diseases, rising cost-efficiency service, growing R&D investment, and a growing focus on product safety.
North America market held the largest market share of 40.68% in 2024. The growing demand for outsourcing and the presence of established market players in countries like the U.S., Canada, and North America is expected to drive the market. Furthermore, established market players within the region offering efficient healthcare visual inspection services in the U.S. is one of the key factors propelling the market growth.
Grand View Research has segmented the healthcare visual inspection services market based on service, application, end-use and region:
Healthcare Visual Inspection Services Product Outlook (Revenue, USD Million, 2018 - 2030)
Pharmaceutical
Medical Device
Healthcare Visual Inspection Services Technology Outlook (Revenue, USD Million, 2018 - 2030)
Manual Visual Inspection (MVI)
Semi-Automated Visual Inspection (SAVI)
Automated Visual Inspection (AVI)
Healthcare Visual Inspection Services By End-use Outlook (Revenue, USD Million, 2018 - 2030)
Pharmaceutical & Biopharmaceutical Companies
Medical Devices Companies
Others
Healthcare Visual Inspection Services Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Thailand
South Korea
Australia
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Healthcare Visual Inspection Services Market
Charles River Laboratories
Jabil Inc.
Lonza Group
Grand River Aseptic Manufacturing.
Vetter Pharma
NIVAGEN
Recipharm AB
Samsung Biologics
SGS SA
West Pharmaceutical Services, Inc.
Adragos Pharma
"The quality of research they have done for us has been excellent..."